New hope for Tough-to-Treat blood cancer

NCT ID NCT05579132

Summary

This study is testing a new drug called MK-1045 for people with a type of blood cancer called B-cell acute lymphoblastic leukemia (B-ALL) that has returned or is not responding to current treatments. The first part of the study aims to find a safe and effective dose. The second part will measure how well the drug works to put the cancer into remission. The study is open to adults and children as young as 2 years old.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hematology Hospital of Chinese Academy of Medical Sciences ( Site 0001)

    RECRUITING

    Tianjin, Tianjin Municipality, 301617, China

    Contact Phone: •••-•••-••••

  • Henan Cancer Hospital-hematology department ( Site 0002)

    RECRUITING

    Zhengzhou, Henan, 450008, China

    Contact Phone: •••-•••-••••

  • Southern Medical University Nanfang Hospital ( Site 0004)

    RECRUITING

    Guangzhou, Guangdong, 510515, China

    Contact Phone: •••-•••-••••

  • The Affiliated Hospital of Xuzhou Medical University ( Site 0007)

    ACTIVE_NOT_RECRUITING

    Xuzhou, Jiangsu, 221006, China

  • The Children's Hospital of Zhejiang University School of Medicine ( Site 0009)

    COMPLETED

    Hangzhou, Zhejiang, 310003, China

  • The First Hospital of Harbin ( Site 0005)

    RECRUITING

    Harbin, Heilongjiang, 150010, China

    Contact Phone: •••-•••-••••

  • The Second Affiliated Hospital of Third Military Medical University ( Site 0008)

    RECRUITING

    Chongqing, Chongqing Municipality, 400037, China

    Contact Phone: •••-•••-••••

  • The Second Hospital of Hebei Medical University ( Site 0003)

    RECRUITING

    Shijiazhuang, Hebei, 050000, China

    Contact Phone: •••-•••-••••

  • Tongji Hospital affiliated to Tongji Medical College of HUST ( Site 0006)

    RECRUITING

    Wuhan, Hubei, 430030, China

    Contact Phone: •••-•••-••••

  • Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology ( Site 0010)

    RECRUITING

    Wuhan, Hubei, 430022, China

    Contact Phone: •••-•••-••••

  • West China Second University Hospital, Sichuan University ( Site 0011)

    COMPLETED

    Chengdu, Sichuan, 610000, China

Conditions

Explore the condition pages connected to this study.